|
2006 Conference Publication The novel compound PRG100 reverses tactile allodynia in STZ-induced diabetic ratsTsui, D. Y. Y., Wyse, B D and Smith, M T (2006). The novel compound PRG100 reverses tactile allodynia in STZ-induced diabetic rats. 2006 Neuroscience Meeting, Atlanta, 14-18 October, 2006. Atlanta: Society for Neuroscience. |
|
2006 Conference Publication PRG100, a novel anti-allodynic agentTsui, D. Y. Y., Wyse, B. D., Monteith, G. R. and Smith, M. T. (2006). PRG100, a novel anti-allodynic agent. 26th Annual Scientific Meeting of the Australian Pain Society, Melbourne, Australia, 9-12 April, 2006. Victoria, Australia: Australian Pain Society. |
|
2005 Conference Publication Chronic administration of dietary L-Arginine reverses opioid hyposensitivity for the relief of tactile allodynia in a rat model of diabetic neuropathyLotfipour, S., Ross, F. B., Brown, L. C. and Smith, M. T. (2005). Chronic administration of dietary L-Arginine reverses opioid hyposensitivity for the relief of tactile allodynia in a rat model of diabetic neuropathy. 11th World Congress on Pain, Sydney, 21-26 August 2005. USA: IASP Press. |
|
2005 Conference Publication Antihyperalgesic and anti-inflammatory effects of RS- & S-ketamine in freunds complete adjuvant (FCA)-induced inflammationEdwards, S. R., Mather, L. E. and Smith, M. T. (2005). Antihyperalgesic and anti-inflammatory effects of RS- & S-ketamine in freunds complete adjuvant (FCA)-induced inflammation. 11th World Congress on Pain, Sydney, 21-26 August 2005. USA: IASP Press. |
|
2005 Conference Publication Investigation of the anti-allodynic and anti-hyperalgesics effects of ACV1 in a rat model of neuropathic painWyse, B. D., Hwang, J. C., Kydd, S., Patterson, M., Nielsen, C. K., Belyea, C., McIntosh, D. and Smith, M. T. (2005). Investigation of the anti-allodynic and anti-hyperalgesics effects of ACV1 in a rat model of neuropathic pain. 11th World Congress on Pain, Sydney, Australia, 21-26 August 2005. Seattle, Wa.: IASP Press. |
|
2005 Conference Publication Insulin implants prevent the temporal development of tactile allodynia and opioid hyposensitivity for 24-wks in streptozotocin (STZ)-diabetic Wistar ratsOtto, K. J., Wyse, B. D., Cabot, P. J. and Smith, M. T. (2005). Insulin implants prevent the temporal development of tactile allodynia and opioid hyposensitivity for 24-wks in streptozotocin (STZ)-diabetic Wistar rats. 11th World Congress on Pain, Sydney, 21-26 Aug. 2005. USA: IASP Press. |
|
2005 Conference Publication Investigation of temporal changes in the anti-allodynic effectiveness of chronically administered gabapentin in a rat model of neuropathic painTan, S., Wyse, B. D., Duffull, S. B. and Smith, M. T. (2005). Investigation of temporal changes in the anti-allodynic effectiveness of chronically administered gabapentin in a rat model of neuropathic pain. 11th World Congress on Pain, Sydney, 21-26 August 2005. USA: IASP Press. |
|
2005 Conference Publication In vivo proof-of-concept study: Commercialisation and regulatory imperativesSmith, M. T. (2005). In vivo proof-of-concept study: Commercialisation and regulatory imperatives. Joint Meeting of ASCEPT and APSA, Melbourne, 4-7 December 2005. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists. |
|
2005 Conference Publication Pain and its treatmentSmith, M. T. (2005). Pain and its treatment. 6th Australian Peptide Conference, Hamilton Island, Australia, 9-15 October, 2005. |
|
2005 Conference Publication Intrathecal XEN2174 produces significant anti-allodynia in morphine-tolerant rats using the CCI-model of persistent neuropathic painSmith, M. T., Nielsen, C. K., Hwang, J. C., Kydd, S., Wyse, B. D., Lewis, R. J. and Drinkwater, R. D. (2005). Intrathecal XEN2174 produces significant anti-allodynia in morphine-tolerant rats using the CCI-model of persistent neuropathic pain. 11th World Congress on Pain, Sydney, Australia, 21-26 August 2005. Seattle, Wa.: IASP Press. |
|
2005 Conference Publication Assessment of fucoidin efficacy in Ab-peptide induced Alzheimer's disease modelPatel, A., Smith, M. T., South, S. M. and Cabot, P. J. (2005). Assessment of fucoidin efficacy in Ab-peptide induced Alzheimer's disease model. Joint Meeting of ASCEPT and APSA, Melbourne, 4-7 December 2005. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists. |
|
2005 Conference Publication What you and your patient need to know about opioidsSmith, M. T., Moore, B. and Molloy, A. (2005). What you and your patient need to know about opioids. Partners in Pain: Patients, Clinicians and Pain Management, Sydney, Australia, 18-19 August, 2005. |
|
2004 Conference Publication Longitudinal investigation of the antinociceptive potency of oxycodone and morphine in the zucker ratTsui, D. Y., Hawes, S., Patterson, M. and Smith, M. T. (2004). Longitudinal investigation of the antinociceptive potency of oxycodone and morphine in the zucker rat. Clinical Pharmacology and Therapeutics 2004, Brisbane, 1-6 August, 2004. Australia: Blackwell Publishing. |
|
2004 Conference Publication Anti-allodynic effects of Xen2174 in rats with neuropathy. AbstractSmith, M. T., Nielsen, C., Lewis, R., Alewood, D. and Drinkwater, R. D. (2004). Anti-allodynic effects of Xen2174 in rats with neuropathy. Abstract. ANZCA Annual Scientific Meeting, Perth, Western Australia, 1-5 May, 2004. Australia: ANZCA. |
|
2004 Conference Publication Anti-allodynic efficacy of the chi-conopeptide, Xen2174, in rats with neuropathic painNielsen, C., Smith, M. T., Lewis, R., Alewood, D. and Drinkwater, R. D. (2004). Anti-allodynic efficacy of the chi-conopeptide, Xen2174, in rats with neuropathic pain. CPT2004: 8th World Congress on Clinical Pharmacology & Therapeutics, Brisbane, Qld, Australia, 1-6 August, 2004. Oxford, United Kingdom: Blackwell Scientific Publications. doi: 10.1111/j.1440-1681.2004.cep_4027.pdf.x |
|
2004 Conference Publication Assessment of working spatial memory utilising T-maze and Morris water-maze for the study of a rodent model of alzheimer's diseasePatel, A., Smith, M. T. and Cabot, P. J. (2004). Assessment of working spatial memory utilising T-maze and Morris water-maze for the study of a rodent model of alzheimer's disease. 4th Annual Queensland Health and Medical Scientific Meeting, Brisbane, 30 November - 1 December 2004. Brisbane: Qld Government. |
|
2004 Conference Publication Opioids and NMDA receptors: Neuro-excitation and abnormal pain behavioursSmith, M. T. (2004). Opioids and NMDA receptors: Neuro-excitation and abnormal pain behaviours. ANZCA Annual Scientific Meeting, Perth, 1-5 May 2004. Australia: ANZCA. |
|
2004 Conference Publication The pro-allodynic effects of morphine-3-glucuronide (M3G) appear to be opioid-receptor mediatedNielsen, C., De Cruz, S. E. and Smith, M. T. (2004). The pro-allodynic effects of morphine-3-glucuronide (M3G) appear to be opioid-receptor mediated. 25th Annual Scientific Meeting of the Australian Pain Society, Canberra, 7-10 March 2004. Australia: Australian Pain Society. |
|
2004 Conference Publication Comparative pharmacokinetics and metabolism of subcutaneous oxycodone in male dark agouti relative to sprague-dawley ratsHuang, L., Edwards, S. R. and Smith, M. T. (2004). Comparative pharmacokinetics and metabolism of subcutaneous oxycodone in male dark agouti relative to sprague-dawley rats. CTP 2004, Brisbane, 1-6 August 2004. Australia: Blackwell Publishing Asia. |
|
2004 Conference Publication Oxycodone: A dose ranging pharmacodynamic study in dogsBubb, L. M., Keates, H. L. and Smith, M. T. (2004). Oxycodone: A dose ranging pharmacodynamic study in dogs. Proc. of Assoc. of Veterinary Anaesthetists, Vienna, Austria, 16-17 September 2004. Austria: |
